Dr. Mike Gieske said since implementing a multidisciplinary screening approach, his healthcare system has seen a 19% decrease in late-stage lung cancers, and they now see more early-stage than late-stage lung cancers. Read more
Nine difference-makers in the field of lung cancer shared their groundbreaking work during the IASLC Lectureship Awards presentations at WCLC 2024. Read more
Experts, including Dr. Melina E. Marmarelis, revealed different approaches to overcoming resistance to immune checkpoint inhibitors. Read more
Dr. Ziming Li and other panelists recently explored encouraging clinical trial data for novel therapies, including garsorasib, olomorasib, fulzerasib, and divarasib. Read more
During the 2024 WCLC, Dr. Shalini Vinod reviewed data showing that a nurse-led care model for geriatric patients outperformed a medical-led model. Read more
Dr. Geoffrey Liu presented results from the TRUST-II trial on the safety and efficacy of taletrectinib in TKI-naive and TKI-pretreated patients. Read more
IASLC Communications Committee members gathered during a WCLC 2024 workshop to share tips on tailoring messages to different audiences, building a strong social media presence, and more. Read more
Global leaders in patient advocacy assembled during the 2024 World Conference on Lung Cancer to shed light on ongoing initiatives. Read more
Dr. Yixian Crystal Chen recently presented results that demonstrate fine particulate matter poses health risks, even for those with no smoking history. Read more
Dr. Benjamin Besse recently discussed detailed findings from the now discontinued CARMEN-LC03 trial. Read more